Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.760,74
0,55%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Nemaura Medical Inc (NMRD) Nemaura Medical Inc (NMRD) Notizie

Nemaura Medical Inc

NMRD
0,1053
0,00 (0,00%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/4/202422:05EDGAR2Form PRE 14C - Other preliminary information statements
10/4/202422:16EDGAR2Form 8-K - Current report
26/2/202422:05EDGAR2Form 8-K - Current report
22/1/202422:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
17/1/202423:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202423:15EDGAR2Form DEF 14A - Other definitive proxy statements
09/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202422:30EDGAR2Form 8-K - Current report
03/1/202413:00EDGAR2Form 8-K - Current report
03/1/202413:00GLOBEImportant Update on Listing Status and Strategic Direction
13/12/202314:00EDGAR2Form 8-K - Current report
13/12/202314:00GLOBENemaura Medical Inc. Receives Positive Nasdaq Listing..
07/12/202316:46EDGAR2Form PRE 14A - Other preliminary proxy statements
21/11/202314:38EDGAR2Form 8-K - Current report
21/11/202314:30GLOBENemaura Medical Inc. Secures $10 Million Non-Dilutive Credit..
14/11/202314:00GLOBENemaura Launches Direct to Consumer Offering of Metabolic..
13/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:15EDGAR2Form 8-K - Current report
13/11/202322:14GLOBENemaura Medical Reports Fiscal Second Quarter 2024 Results..
12/10/202322:05EDGAR2Form 8-K - Current report
06/10/202322:10EDGAR2Form 8-K - Current report
26/9/202315:50GLOBENemaura Medical Announces Appointment of Mr Nikolai Rozanov..
22/9/202321:05GLOBEMaxim Group LLC to Host the Virtual Tech Conference Series:..
18/9/202315:15GLOBENemaura Medical to Present at the Maxim Group Emerging..
14/9/202314:00EDGAR2Form 8-K - Current report
14/9/202314:00GLOBENemaura Medical Provides Update on Nasdaq Compliance Status..
13/9/202314:03EDGAR2Form 8-K - Current report
13/9/202314:00GLOBENemaura Medical Announces Interim Results from its..
12/9/202315:26GLOBENemaura Medical Announces Participation at HLTH 2023, Las..
11/9/202322:41EDGAR2Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8)
11/9/202315:00EDGAR2Form 8-K - Current report
08/9/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/9/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
17/8/202314:30EDGAR2Form 8-K - Current report
17/8/202314:30GLOBENemaura Medical Announces SFDA Approval of sugarBEAT®
14/8/202314:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:30EDGAR2Form 8-K - Current report
14/8/202314:30GLOBENemaura Medical Reports Fiscal First Quarter 2024 Results..
11/8/202323:07EDGAR2Form 8-K - Current report
11/8/202322:05GLOBENemaura Medical Secures $6.5m in Non-Dilutive Funding
10/8/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202322:08EDGAR2Form POS AM - Post-Effective amendments for registration..
17/7/202315:30EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
14/7/202315:25GLOBENemaura Medical Reports Financial Results and Provides..
14/7/202315:18EDGAR2Form 8-K - Current report
13/7/202322:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/6/202312:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
27/6/202315:00GLOBENemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56..
22/6/202314:00GLOBENemaura Medical to Participate at the Collision Conference..
Apertura: Min: Max:
Chiusura: 0,1053

La tua Cronologia

NASDAQ
NMRD
Nemaura Medical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network